Healthcare mergers decreased in the first half of 2020, but not to the extent expected as a result of the Covid-19 pandemic. Reports by Pricewaterhouse Coopers and Kaufman Hall showed a decline in mergers and acquisitions, but still reported sustained interest from buyers
The deal between the two diagnostics giants, announced Tuesday, includes Thermo Fisher's assumption of $1.4 billion in Qiagen's debt. Qiagen has been developing diagnostics for detecting the novel coronavirus SARS-CoV-2.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.